Article Text

Download PDFPDF
Vascular occlusion in serpiginous choroidopathy
  1. E Baglivo1,
  2. S Boudjema1,
  3. C Pieh1,
  4. A B Safran1,
  5. C Chizzolini2,
  6. C Herbort3,
  7. N Rao4
  1. 1Clinique d’Ophtalmologie-Hôpitaux Universitaires de Genève, Rue Alcide-Jentzer, 22-CH 1205 Geneva, Switzerland
  2. 2Département d’immunologie clinique-Hôpitaux Universitaires de Genève, Rue Micheli du Crest-CH 1205 Geneva, Switzerland
  3. 3Clinique de la Source. Avenue des Bergières, Lausanne, Switzerland
  4. 4Doheny Eye Institute. University of Southern California Keck School of Medicine, Los Angeles, CA, USA
  1. Correspondence to: Edoardo Baglivo Hôpitaux Universitaires de Genève, Clinique d’Ophtalmologie-Uveitis Department, rue Alcide-Jentzer, 22, CH-1205 Geneva, Switzerland;

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Serpiginous choroidopathy (SC) is a rare disease inducing a permanent loss of vision, caused by a progressive destruction of the retinal pigment epithelium and choriocapillaris. Until now, no aetiology or predisposing factors have been reported. SC, usually, affects both eyes and occurs in patients between the fourth and sixth decade, without any sex or race predilection. Clinically, deep cream-coloured lesions develop in the peripapillary region and then along the retinal vessels, centrifugally, inducing an atrophy of the retina. Other lesions may develop, isolated, in the posterior segment. The anterior segment is typically quiet; nevertheless, a mild anterior uveitis and/or vitritis have been observed. The course of the disease results in successive attacks and recurrences inducing permanent retinal atrophic changes and subsequently an irreversible loss of vision. Choroidal neovascularisation may occasionally develop. No specific diagnostic tests are available such that the diagnosis of SC is mostly clinical.1


A 30 year old Indian man presented with a history of painless progressive visual loss affecting the right eye. No other ophthalmological or systemic complaints were present. His medical history was unremarkable.

Ophthalmological examination revealed a visual acuity of 20/50 in the right eye and 20/20 in the left eye without a correction in both eyes. Anterior segment examination revealed a mild inflammation with fine keratic precipitates on the inferior …

View Full Text